HENRY CHRISTIAN O 4

What Happened

• Christian Henry, President & CEO of Pacific Biosciences (PACB), received equity awards on 2026-02-27: 920,810 restricted stock units (RSUs) and a derivative award covering 1,841,621 shares (both granted at $0.00). No cash was exchanged — these are compensation awards rather than open‑market purchases or sales.

Key Details

• Transaction date: 2026-02-27; Form 4 filed 2026-03-03 (timely within required filing window).
• Awards granted: 920,810 RSUs @ $0.00; 1,841,621 derivative/option-format shares @ $0.00 — total 2,762,431 shares granted.
• Vesting: RSUs vest in equal annual installments on Feb 15 of 2027, 2028 and 2029 (F1). The derivative/option award vests in 36 equal monthly installments beginning March 27, 2026 (F2).
• Shares owned after the transaction: not disclosed in the filing.
• Filing status: reported on a Form 4 and appears timely (filed within two business days after the grant date).

Context

• RSUs are a promise to deliver shares if vesting/service conditions are met; the option-like award vests monthly over three years. Neither award involved an immediate exercise or sale of shares — they are forward-looking compensation. Such grants are common for executives and reflect compensation structure rather than direct insider buying or selling activity.